Clinical trials
Recruiting Stomach Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
537 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2008 | 2 |
| 2011 | 1 |
| 2013 | 8 |
| 2016 | 5 |
| 2017 | 7 |
| 2018 | 10 |
| 2019 | 7 |
| 2020 | 18 |
| 2021 | 41 |
| 2022 | 41 |
| 2023 | 65 |
| 2024 | 109 |
| 2025 | 128 |
| 2026 | 92 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 537 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 16 |
| AstraZeneca | 8 |
| Nanfang Hospital, Southern Medical University | 8 |
| National Cancer Institute (NCI) | 8 |
| Chinese University of Hong Kong | 7 |
| The First Affiliated Hospital with Nanjing Medical University | 7 |
| Tianjin Medical University Cancer Institute and Hospital | 7 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 7 |
| Beijing Friendship Hospital | 6 |
| City of Hope Medical Center | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 537 |
| Esophageal Neoplasms | 115 |
| Colorectal Neoplasms | 88 |
| Pancreatic Neoplasms | 78 |
| Breast Neoplasms | 69 |
| Lung Neoplasms | 57 |
| Ovarian Neoplasms | 56 |
| Neoplasms | 49 |
| Carcinoma, Non-Small-Cell Lung | 48 |
| Colonic Neoplasms | 41 |
Trials
Showing 76 to 100 of 537. Each trial links to its page on Pharma Observatory.
437 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.